Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530 | See remarks | May 20, 2025 | May 22, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ginkgo Bioworks Holdings, Inc.
Report date May 20, 2025 · Filed May 22, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 46,226 |
Ending reported balance
After 2025-05-21 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2025-05-20 · Exercise / conversion · Acquired 454 · Balance 45,907 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 2 · 2025-05-20 · Exercise / conversion · Acquired 453 · Balance 46,360 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 3 · 2025-05-20 · Exercise / conversion · Acquired 572 · Balance 46,932 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Row 4 · 2025-05-21 · Sale · Disposed 706 · Balance 46,226 F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,614 |
Reported balance
After 2025-05-20 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2025-05-20 · Exercise / conversion · Disposed 454 · Balance 3,614 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,970 |
Reported balance
After 2025-05-20 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-05-20 · Exercise / conversion · Disposed 453 · Balance 9,970 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 19,488 |
Reported balance
After 2025-05-20 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2025-05-20 · Exercise / conversion · Disposed 572 · Balance 19,488 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F4: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.
F3: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023.
F4: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 03, 2024 Filed Dec 5, 2024 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028727 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,119 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028727 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 17:03 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 484 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-028727 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,094 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| November 04, 2024 Filed Nov 6, 2024 16:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 1,322 | $7.58 | $10,015.47 |
DisclosureSEC source: 0001127602-24-026589 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,610 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 16:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 36 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026589 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,427 Underlying: Class A Common Stock · 36 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F7 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 16:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026589 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,920 Underlying: Class A Common Stock · 572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 16:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026589 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,688 Underlying: Class A Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 16:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026589 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,364 Underlying: Class A Common Stock · 1,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 16:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 36 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026589 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,932 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 16:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026589 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 16:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026589 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| November 01, 2024 Filed Nov 6, 2024 16:27 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-026589 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| October 04, 2024 Filed Oct 8, 2024 16:25 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 1,217 | $8.35 | $10,163.17 |
DisclosureSEC source: 0001127602-24-025332 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,237 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 16:25 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 46 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025332 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,463 Underlying: Class A Common Stock · 46 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F7 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 16:25 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025332 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,492 Underlying: Class A Common Stock · 572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 16:25 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025332 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,141 Underlying: Class A Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 16:25 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025332 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,998 Underlying: Class A Common Stock · 1,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 16:25 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 46 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025332 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,454 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 16:25 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025332 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 16:25 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025332 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,836 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| October 03, 2024 Filed Oct 8, 2024 16:25 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-025332 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 16:26 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 1,148 | $6.17 | $7,085.46 |
DisclosureSEC source: 0001127602-24-023999 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,749 F5 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 16:26 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 34 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023999 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,509 Underlying: Class A Common Stock · 34 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F8 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F4 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F4 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 16:26 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023999 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,064 Underlying: Class A Common Stock · 572 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F7 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F7 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 16:26 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023999 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,594 Underlying: Class A Common Stock · 453 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 16:26 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023999 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,632 Underlying: Class A Common Stock · 1,634 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 16:26 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 34 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023999 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F4 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 16:26 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 572 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023999 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 16:26 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 453 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023999 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| September 11, 2024 Filed Sep 16, 2024 16:26 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,634 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-023999 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · balance_after: This amount reflects the 1-for-40 reverse stock split effected by the Issuer on August 20, 2024. Read SEC document |
| August 02, 2024 Filed Aug 6, 2024 16:37 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 63,567 | $0.29 | $18,243.73 |
DisclosureSEC source: 0001127602-24-021718 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,088,186 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 16:37 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,636 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021718 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 622,141 Underlying: Class A Common Stock · 1,636 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F7 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 16:37 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 22,917 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021718 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 985,417 Underlying: Class A Common Stock · 22,917 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 16:37 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021718 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 561,875 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 16:37 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,449 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021718 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,639 Underlying: Class A Common Stock · 65,449 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 16:37 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,636 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021718 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,151,753 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 16:37 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 22,917 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021718 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,150,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 16:37 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021718 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,127,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| August 01, 2024 Filed Aug 6, 2024 16:37 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,449 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-021718 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,109,075 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 02, 2024 Filed Jul 5, 2024 16:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 49,162 | $0.33 | $16,026.81 |
DisclosureSEC source: 0001127602-24-020163 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,043,626 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 16:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020163 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 623,777 Underlying: Class A Common Stock · 1,635 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F7 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 16:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 22,916 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020163 · form4.xml · derivative · entry 8 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,008,334 Underlying: Class A Common Stock · 22,916 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. F6 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2024. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 16:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020163 · form4.xml · derivative · entry 7 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 580,000 Underlying: Class A Common Stock · 18,125 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F5 · derivative.exercise_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. F5 · derivative.expiration_date: The RSUs vest in 48 equal monthly installments, which began on April 1, 2023. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 16:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionRestricted Stock Units · Derivative | 65,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020163 · form4.xml · derivative · entry 6 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 516,088 Underlying: Class A Common Stock · 65,450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · derivative.expiration_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 16:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 1,635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020163 · form4.xml · nonDerivative · entry 4 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,092,788 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F3 · price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 16:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 22,916 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020163 · form4.xml · nonDerivative · entry 3 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,091,153 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 16:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 18,125 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020163 · form4.xml · nonDerivative · entry 2 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,068,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| July 01, 2024 Filed Jul 5, 2024 16:01 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass A Common Stock | 65,450 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-020163 · form4.xml · nonDerivative · entry 1 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,050,112 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 17:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 48,866 | $0.55 | $26,827.43 |
DisclosureSEC source: 0001127602-24-017958 · form4.xml · nonDerivative · entry 5 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 984,662 F4 · kind: Represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock and/or restricted stock units. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| May 31, 2024 Filed Jun 5, 2024 17:04 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | Exercise / conversionClass B Common Stock · Derivative | 1,638 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-017958 · form4.xml · derivative · entry 9 Dmytruk Mark E. · CIK 0001873507 · See remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 625,412 Underlying: Class A Common Stock · 1,638 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F2 · kind: Represents the conversion of shares of Class B Common Stock to shares of Class A Common Stock. F7 · price: Includes shares of Class B Common Stock that are subject to vesting conditions. F3 · derivative.exercise_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. F3 · derivative.expiration_date: Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.